Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
CLASP is a research study to investigate the safety and effectiveness of simvastatin (a
cholesterol lowering drug or statin) to slow the progression of Alzheimer's disease (AD).
Statins are commonly used to treat high cholesterol levels, which increase the risk of heart
disease and stroke.